Skip to content
thispeptide

NativeMed

NativeMed connects patients with virtual clinical care for weight management and longevity treatments. Its monthly prices are distinct from longer-plan headlines, and later consultation costs need a closer look.

Review by Leah Garner, clinical-evidence editor · Updated October 2026

The short version

The current product menu is specific about several preparations, with a consultation option described in the terms. Confirm the pharmacy, monitoring and paid maintenance arrangements before assuming every stage of care is included.

Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

FDA warning letter on record: Letter 728287 · June 2026

Lowest listed: Semaglutide injection, from $179/mo

Visit NativeMed →

NativeMed arranges prescriptions through an online platform, with weight-management products and a separate longevity menu. The current pages name compounded semaglutide and tirzepatide injections, NAD+ injections and injectable sermorelin. These products address different goals and should not be selected as a single interchangeable wellness package. The public product process starts with a questionnaire, then a provider decides whether a preparation is appropriate. The company’s footer distinguishes its administrative role from clinical decisions and pharmacy compounding. A product being available on the menu does not mean it is suitable for a particular patient.

What NativeMed prescribes, by goal

Weight

  • SemaglutideFDA-approved
    • Injection (compounded)From $179/mo
  • TirzepatideFDA-approved
    • Injection (compounded)From $259/mo

The semaglutide and tirzepatide pages explicitly identify compounded injections. They acknowledge that those preparations are not approved generics or demonstrated substitutes for approved products. Ask what patient-specific need supports the preparation being prescribed, and how the clinician will review treatment response. The same-price-at-any-dose promise is a payment term, rather than a reason to change medication without reassessment.

Longevity

  • NAD+Compounding conditions apply
    • Injection (compounded)From $189/mo

The NAD+ page describes a compounded injection, while the sermorelin page identifies an injectable preparation. Both use healthy-aging language. Ask which measurable problem the clinician intends to address and what would justify continuing treatment. Product-specific pharmacy and monitoring information are more useful than broad energy or recovery promises.

Recovery

  • SermorelinCompounding conditions apply

    Listed by the seller; no price we hold.

    Sleep

    • SermorelinCompounding conditions apply

      Listed by the seller; no price we hold.

      Each “From” figure is the seller’s own starting price, in the unit the seller states. Where a required fee or a package length changes what one month costs, the smaller line under it is our arithmetic, not a figure the seller prints. Compounded preparations are not FDA-approved.

      Who prescribes

      A licensed clinician

      The platform terms identify NativeMed LLC and describe the medical practice as NativeMed Healthcare LLC. They say the practice is independently owned by a physician and that providers make clinical decisions separately from the platform. That identifies a clinical party, but not the person assigned to every applicant. Ask for the prescriber’s name and practice on the actual consent and prescription. The website describes U.S. pharmacies without naming the dispenser for the individual order. The clinician and pharmacist have different responsibilities, so obtain contact arrangements for both before starting treatment.

      The product pages describe a questionnaire followed by an individualized provider review. The program agreement also offers an initial virtual consultation call, making a live visit an available part of the service. It says that consultation is free if the person proceeds, with a possible fee if they decline afterward. Separate maintenance calls are offered after the initial program and carry an additional unpublished charge. Ask how routine prescription follow-up differs from those paid maintenance appointments. Support messaging and delivery coordination do not automatically establish a full ongoing clinical schedule. A patient should know what happens if an examination or specialist assessment is needed.

      Are labs required?

      Not mentioned

      No universal public laboratory panel or complete testing charge is established for the entire treatment menu. The agreement allows providers to recommend outside diagnostic services and makes the patient responsible for resulting bills. Ask what baseline reports are required for the selected preparation and who reviews additional results. In particular, a longevity purchase should not be treated as evidence that endocrine or nutritional causes of symptoms have been assessed. A remote consultation can be useful while still leaving a need for local examination or testing. Clarify those boundaries before accepting a longer program.

      Ready to start with NativeMed?

      Lowest listed price: Semaglutide injection, from $179/mo. Confirm it on the seller’s own site.

      What it claims, and what it cites

      FDA sent NativeMed a warning letter dated June 8, 2026 about compounded semaglutide and tirzepatide advertising and pictured labeling. It challenged suggestions that the platform was the compounder or that the preparations had approved-product standing. The current footer more clearly separates NativeMed from the dispensing pharmacy and acknowledges that compounded drugs are not FDA-approved. That distinction should remain part of the clinical discussion. The dated letter does not determine whether a present individual prescription is appropriate or establish a defect in a patient’s vial. Pharmacy identity and the specific preparation still need verification.

      How it bills

      Selecting Monthly on the public product pages shows continuing semaglutide at $179 and tirzepatide at $259 per month. Their first-month figures are lower. NAD+ shows $189 monthly, while sermorelin shows $159. The lower general headlines apply to other selections. The program agreement describes conditional $25 consultation and missed-appointment charges, plus separate paid maintenance calls. Its refund policy allows a limited request within twenty-four hours before shipment, with an administrative deduction whose amount is not published. Confirm whether that policy applies to the selected longevity preparation as well as the weight-management program.

      For and against

      • For: Named medical practice in the terms
      • For: Live consultation option described
      • For: Separate monthly product selections
      • For: Compounded product limitations acknowledged
      • Against: Dispensing pharmacy not named for the order
      • Against: Maintenance-call price is not published
      • Against: Conditional consultation and missed-visit charges
      • Against: Limited refund window with an unspecified deduction

      The evidence behind what it sells

      Right for

      Someone who wants a choice of named treatment programs and will confirm the specific clinician, pharmacy and ongoing appointment charges.

      Look elsewhere if

      A patient assuming the lowest headline is the ordinary monthly price or that later maintenance consultations are automatically included.

      Other sellers for weight

      NativeMed

      Frequently asked questions

      Are the lowest headline prices the independent monthly options?
      No. Selecting Monthly changes the public product amounts. Obtain the selected plan and continuing amount, rather than relying on the page’s general from figure.
      Is every consultation free?
      The agreement describes a free initial call when proceeding, but possible $25 charges in specified circumstances and paid maintenance calls later.
      Does the FDA letter establish the quality of my prescription?
      No. The June 2026 letter addresses the named company’s advertising and labeling representations. The actual pharmacy and preparation still need verification.
      What should be asked about testing?
      Confirm the baseline reports, any outside testing charges and who follows up the results for the selected treatment.

      Sources

      • Current semaglutide product and monthly selection
      • Tirzepatide preparation and plan choices
      • NAD+ prescription service
      • Sermorelin injection menu
      • Practice identity and clinical responsibilities
      • Consultation charges and maintenance calls
      • Limited cancellation refund policy
      • FDA warning dated June 8, 2026

      See what NativeMed prescribes today

      NativeMed sets its own prices, plans and the states it serves. Check them before you start.

      Written by Leah Garner from NativeMed’s own public pages, against the published methodology. No outcome is claimed first-hand and no score is given. A partnership never changes what this page says; see how the site is paid.